Should the consensus guidelines' specific criteria for the diagnosis of invasive fungal infection be changed?
SourceClinical Infectious Diseases, 41 Suppl 6, supplement 6, (2005), pp. S377-80
Article / Letter to editor
Display more detailsDisplay less details
Blood Transfusion and Transplantation Immunology
Radboud University Nijmegen Medical Centre
Clinical Infectious Diseases
vol. 41 Suppl 6
iss. supplement 6
SubjectUMCN 1.4: Immunotherapy, gene therapy and transplantation
The introduction of a standardized set of criteria to define invasive fungal infections has fulfilled a need. The criteria make comparisons between various clinical studies more easy and facilitate discussions of trial designs. However, application of the criteria in practice has indicated that some criteria for possible disease (in particular, antibiotic-resistant fever during neutropenia) are rather unspecific and allow the inclusion of patients who are unlikely to have an invasive fungal infection in trials. On the other hand, new diagnostic tools have been validated sufficiently to consolidate the effect of the criteria on the diagnosis of invasive fungal infections. Finally, it has become evident that changing medical practices with deleterious consequences for the innate immune system extend the population at risk for invasive fungal infections. This combination of factors has urged researchers to reconsider the continuing appropriateness of the current definitions.
Upload full text